Stable Buyback daga Abokan ciniki CAS 782487-28-9 Rosiptor Kyakkyawan Inganci Mafi kyawun Farashin Hot Sale Babban Tsaftataccen Tsaro 99% kwafi

Asalin samfurin semaglutide Novo Nordisk ne ya haɓaka kuma an nuna shi ga manya masu nau'in ciwon sukari na 2. Sunan kasuwancin samfurin allura shine Ozempic®, wanda za'a iya amfani dashi sau ɗaya a mako. Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ce ta amince da ita a ranar 5 ga Disamba, 2017, da Hukumar Kula da Magunguna ta Turai (EMA) a ranar 8 ga Fabrairu, 2018. Hukumar Kula da Magunguna da Magunguna ta Japan ta amince da ita don tallata shi. PMDA) a ranar 23 ga Maris, 2018. An gabatar da aikace-aikacen talla ga Hukumar Kula da Kayayyakin Kiwon Lafiya ta kasar Sin (NMPA) a ranar 4 ga Afrilu, 2020, kuma a halin yanzu ana kan nazari da amincewa. Sunan littafin sinadarai na samfurin kwamfutar hannu na baka, Rybelsus®, FDA ta amince da ita a ranar 20 ga Satumba, 2019, EMA na Turai a cikin Maris 2020, da PMDA na Japan a watan Yuni 2020. Shine maganin GLP-1 na baka na farko a duniya. Ana iya amfani da Semaglutide (0.5 MG ko allurar 1 MG) don kula da nau'in ciwon sukari na 2 a cikin manya. Wannan magani shine agonist mai karɓar glucagon-kamar peptide (GLP-1), wanda ke motsa ƙwayar insulin kuma yana rage ƙwayar glucagon. Rabin rayuwar daurin albumin na jini shine mako 1, don haka yakamata a gudanar da shi sau ɗaya a mako tare da alkalami da aka riga aka cika. Taimakawa abinci da motsa jiki don inganta sarrafa sukarin jini a cikin manya masu fama da ciwon sukari na 2.